Phase II study of bevacizumab and pemetrexed for recurrent or persistent epithelial ovarian, fallopian tube or primary peritoneal cancer

Andrea R. Hagemann, Akiva P. Novetsky, Israel Zighelboim, Feng Gao, L. Stewart Massad, Premal H. Thaker, Matthew A. Powell, David G. Mutch, Jason D. Wright

Research output: Contribution to journal › Article › peer-review

23 Scopus citations

Fingerprint

Dive into the research topics of 'Phase II study of bevacizumab and pemetrexed for recurrent or persistent epithelial ovarian, fallopian tube or primary peritoneal cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences